Toggle Nav
Close
  • Menu
  • Setting

Rifampin

Catalog No.
B2021
DNA-dependent RNA polymerase inhibitor
Grouped product items
SizePriceStock Qty
10mM (in 1mL DMSO)
$61.00
In stock
1g
$55.00
In stock
5g
$209.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Rifampin (CAS 13292-46-1) is an antibiotic belonging to the rifamycin family, characterized by bactericidal activity via selective inhibition of bacterial DNA-dependent RNA polymerase. This inhibition disrupts transcriptional initiation by preventing RNA synthesis, leading to impaired bacterial protein biosynthesis and subsequent cell death. In biomedical research, rifampin serves as an essential tool for investigations into bacterial resistance mechanisms, transcriptional regulation, and synthetic biology studies that rely on specific transcription inhibition.

Product Citation

Chemical Properties

Physical AppearanceA solid
StorageStore at -20°C
M.Wt822.94
Cas No.13292-46-1
FormulaC43H58N4O12
Solubility≥26.25 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
SDFDownload SDF
Canonical SMILESO[C@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)/C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@]3(C)OC4=C(C)C(O)=C2C(C(/C1=C/NN5CCN(C)CC5)=O)=C4C3=O)OC)OC(C)=O
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Animal experiment:[1]

Animal models

Male Parkes strain mice (20 ~ 25g) inoculated in the left hind footpad with 1 × 104 viable units of Mycobacterium marinum (M. marinum)

Dosage form

0.003%, 0.01%, 0.03% and 0.1% rifampin in the diet

Administered by oral route

Applications

Rifampin at dosages of 0.003% and 0.01% in the diet was not suppressive to bacillary growth. A dosage of 0.03% resulted in a transient fall in viable bacillary count, which was followed by recovery of growth 10 days after inoculation. The highest dose (0.1%) was highly bactericidal, with the viable count of M. marinum reduced to, and maintained below, the detectable level of 2.0 × 102 organisms per foot pad after 7 days of treatment.

Note

The technical data provided above is for reference only.

References:

1. Banerjee DK, Holmes IB. In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum. Chemotherapy, 1976, 22(3-4): 242-252.

Quality Control